Recombinant Human IL-4 Receptor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human IL-4 Receptor, covering 2016-03-07 to 2016-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Human IL-4 Receptor Used in Treatment of Asthma [Phase 2]